Panretin Gel
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
General Information
Panretin (alitretinoin) Gel, 0.1%, has been approved for the
treatment of cutaneous lesions in patients with AIDS-related
Kaposi's sarcoma.
